|
|
Article: Drug-eluting stents come under spotlight.(HEALTH AND SAFETY)
- Article from:
- Biomedical Materials
- Article date:
- November 1, 2006
CopyrightCOPYRIGHT 2006 International Newsletters. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Recent information suggesting a small but significant increase in the rate of death and heart attack possibly due to stent thrombosis in patients treated with drug-eluting stents (DES) has prompted the US Food and Drug Administration (FDA) to state that a more formal evaluation of this information is now necessary.
(See also items above UK consortium wins funding for regnerative stent and Drug-eluting stents come under spotlight.)
The FDA will convene a public meeting of the Circulatory System Devices Advisory Panel by the end of the year in an effort to examine all the issues.
The specific studies that have prompted the recent media inquiries are the Basket-Late ...